Trexquant Investment’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-277,535
| Closed | -$3.89M | – | 1890 |
|
|
2026
Q1 | $3.89M | Buy |
277,535
+248,349
| +851% | +$3.35M | 0.03% | 756 |
|
|
2025
Q4 | $328K | Sell |
29,186
-105,242
| -78% | -$1.2M | ﹤0.01% | 1435 |
|
|
2025
Q3 | $1.55M | Buy |
134,428
+120,348
| +855% | +$1.41M | 0.02% | 1000 |
|
|
2025
Q2 | $172K | Sell |
14,080
-178,870
| -93% | -$2.25M | ﹤0.01% | 1458 |
|
|
2025
Q1 | $2.76M | Buy |
+192,950
| New | +$3.01M | 0.03% | 747 |
|
|
2024
Q4 | – | Sell |
-13,208
| Closed | -$317K | – | 1545 |
|
|
2024
Q3 | $317K | Buy |
13,208
+1,150
| +10% | +$26.3K | ﹤0.01% | 1339 |
|
|
2024
Q2 | $240K | Sell |
12,058
-8,265
| -41% | -$161K | ﹤0.01% | 1411 |
|
|
2024
Q1 | $405K | Sell |
20,323
-27,023
| -57% | -$522K | 0.01% | 1211 |
|
|
2023
Q4 | $1.06M | Buy |
47,346
+9,803
| +26% | +$202K | 0.02% | 805 |
|
|
2023
Q3 | $759K | Buy |
+37,543
| New | +$851K | 0.02% | 857 |
|
|
2023
Q1 | – | Sell |
-25,619
| Closed | -$693K | – | 1432 |
|
|
2022
Q4 | $693K | Buy |
25,619
+11,186
| +78% | +$274K | 0.02% | 784 |
|
|
2022
Q3 | $314K | Sell |
14,433
-2,871
| -17% | -$75K | 0.01% | 1010 |
|
|
2022
Q2 | $473K | Sell |
17,304
-33,915
| -66% | -$974K | 0.02% | 853 |
|
|
2022
Q1 | $1.72M | Buy |
51,219
+21,368
| +72% | +$688K | 0.08% | 302 |
|
|
2021
Q4 | $1.03M | Buy |
29,851
+22,498
| +306% | +$727K | 0.06% | 375 |
|
|
2021
Q3 | $229K | Buy |
+7,353
| New | +$249K | 0.02% | 888 |
|
|
2021
Q2 | – | Sell |
-5,763
| Closed | -$252K | – | 1092 |
|
|
2021
Q1 | $252K | Buy |
+5,763
| New | +$270K | 0.02% | 839 |
|
|
2018
Q4 | – | Sell |
-18,670
| Closed | -$1.28M | – | 1026 |
|
|
2018
Q3 | $1.28M | Sell |
18,670
-9,413
| -34% | -$606K | 0.1% | 291 |
|
|
2018
Q2 | $1.61M | Buy |
+28,083
| New | +$1.48M | 0.11% | 268 |
|
|
2016
Q3 | – | Sell |
-16,728
| Closed | -$544K | – | 727 |
|
|
2016
Q2 | $544K | Buy |
16,728
+2,828
| +20% | +$86.6K | 0.07% | 449 |
|
|
2016
Q1 | $399K | Buy |
+13,900
| New | +$370K | 0.05% | 643 |
|
|
2015
Q4 | – | Sell |
-25,600
| Closed | -$728K | – | 1002 |
|
|
2015
Q3 | $728K | Buy |
25,600
+12,300
| +92% | +$429K | 0.06% | 565 |
|
|
2015
Q2 | $538K | Buy |
+13,300
| New | +$597K | 0.06% | 583 |
|
Other funds holding AVNS
NAM
TAL
FTCM
Trexquant Investment's AVNS Position: Q2 2026 in Review
Trexquant Investment sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 277,535 shares — an estimated $3.89M sold.
Trexquant Investment first reported a position in AVNS in Q2 2015 and held it in 23 quarters. The position peaked at $3.89M in Q1 2026. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.
- Trexquant Investment reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
- Trexquant Investment sold 277,535 Avanos Medical shares in Q2 2026, an estimated $3.89M.
- Trexquant Investment first reported a position in Avanos Medical in Q2 2015 and held it in 23 quarters.
- Trexquant Investment's Avanos Medical position peaked at $3.89M in Q1 2026.
- 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.
Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.